Law firms including Hagens Berman and Levi & Korsinsky set an August 3, 2026, lead plaintiff deadline for GeneDx Holdings Corp. investors. The securities fraud class action alleges misleading statements regarding the Fabric Genomics acquisition.
GeneDx shares plunged nearly 50% during a single session. This crash occurred on May 4, 2026. The company reported a $31.2 million impairment charge linked to Fabric Genomics. Management also lowered full-year 2026 revenue guidance.
The lawsuit covers investors who purchased stock starting April 16, 2025. The class period ends on May 4, 2026. It cites undisclosed integration issues and deteriorating financial metrics.